Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa

Ulcerative colitis (UC) is a chronic relapsing disease featuring aberrant accumulation of neutrophils in colonic mucosa and the luminal space. Although significant advances in UC therapy have been made with the development of novel biologics and small molecules targeting immune responses, success of...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzanares, Laura D., David, Joseph, Ren, Xingsheng, Yalom, Lenore K., Piccolo, Enzo B., Dehghan, Yalda, David, Aidan J., Hanauer, Stephen B., Sumagin, Ronen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614091/
https://www.ncbi.nlm.nih.gov/pubmed/36313299
http://dx.doi.org/10.3389/fphar.2022.1011115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614091/
https://www.ncbi.nlm.nih.gov/pubmed/36313299
http://dx.doi.org/10.3389/fphar.2022.1011115

Ejemplares similares